The Therapeutic Potential of PLGA Nanoparticles in Alzheimer's Disease
FDA approved PLGA nanoparticles infiltrate the CNS in 5xFAD mice and induce an immunoregulatory effect on myeloid cells, as well as behavioral phenotypes which mimic aged matched wild-type mice, suggesting that nanoparticle based immunotherapy could a be a promising strategy in treating Alzheimer's disease.
Authors
- Igal Ifergan
- Bret Sanders
Institutions
- University of Cincinnati (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_105801
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00